Navidea Biopharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This dashboard includes a questions and answers table on Navidea Biopharmaceuticals Inc. If you are employed by Navidea Biopharmaceuticals Inc and you would like to licence your ESG rating, please get in touch. This ESG score for Navidea Biopharmaceuticals Inc indicates its transparency towards the UN Sustainable Development Goals.
Navidea Biopharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.9; made up of an environmental score of 4.0, social score of 8.0 and governance score of 8.0.
6.9
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 355 | Xbrane Biopharma AB | 7.0 | High |
| 355 | Xenetic Biosciences Inc | 7.0 | High |
| 387 | Navidea Biopharmaceuticals Inc | 6.9 | High |
| 387 | Advanced Medical Solutions Group PLC | 6.9 | High |
| 387 | Acrux Ltd | 6.9 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Navidea Biopharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Navidea Biopharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Navidea Biopharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Navidea Biopharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Navidea Biopharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Navidea Biopharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Navidea Biopharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages for a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (PET), gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. It develops NAV3-31, which has completed Phase IIb clinical trials for evaluating imaging repeatability, reproducibility, and stability, as well as the capacity of Tc99m tilmanocept imaging for treatment of anti-tumor necrosis factor alpha therapy in patients with moderate to severe rheumatoid arthritis (RA); NAV3-35 that is in a Phase IIb clinical trial for RA imaging; NAV3-33, which is in Phase III clinical trial for RA; and NAV3-32, which is Phase 2b trial for RA-involved joints. The company is also developing Tc99m tilmanocept for cardiovascular, kaposi's sarcoma, tuberculosis, and other immunotherapeutic applications. The company was formerly known as Neoprobe Corporation and changed its name to Navidea Biopharmaceuticals, Inc. in January 2012. Navidea Biopharmaceuticals, Inc. was incorporated in 1983 and is headquartered in Dublin, Ohio.